| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |